Skip to main content
ACG 2024 Annual Meeting Main banner
Icon Legend
This session is not in your Favorites.
This session is in your Favorites. Click again to remove it.
Presentation Icons
ACG Award Winner
ACG Award Winner
ACG Newsworthy Abstract
ACG Newsworthy Abstract
Registration Required
Registration Required
No CME
No CME
On-Demand Video
On-Demand Video
Livestream
Livestream
Back

Niloy Samadder, MD, MSc, FACG (he/him/his)

Professor of Medicine
Mayo Clinic
Phoenix, AZ

N. Jewel Samadder, MD, MSc, FACG, is a Professor and Consultant in the Division of Gastroenterology and Hepatology, Department of Internal Medicine and a joint appointment in the Department in the of Clinical Genomics at the Mayo Clinic in Arizona. He is the Vice Chair of the Department of Medicine and is also the Enterprise Co-Director for Individualized/Precision Medicine for the Mayo Clinic Comprehensive Cancer Center (as of July 2022) and Associate Medical Director of the Department of Development. Dr. Samadder received his medical degree from the University of Toronto (Canada) where he also completed his internal medicine residency. He subsequently completed a fellowship in Gastroenterology at the University of Michigan (Ann Arbor, MI) and an Advanced Endoscopy fellowship at the Mayo Clinic (Rochester, MN). During his gastroenterology fellowship, Dr. Samadder also completed his Master’s in Healthcare Research at the University of Michigan Medical School and obtained specialized training in Cancer Genetics at the University of Michigan Comprehensive Cancer Center under the mentorship of Dr. Stephen Gruber. His clinical interests focus on the diagnosis and management of patients with inherited forms of cancers, most notably those with gastrointestinal cancer syndromes such as Lynch Syndrome and Familial Adenomatous Polyposis. He has been an author of national and international guidelines for the management of patients with familial colon cancers and has led several multi-center clinical trials for the prevention of cancer in patients with FAP. Most recently he led a multi-center clinical trial of proactive multi-gene panel testing in all newly diagnosed cancer patients across three Mayo Clinic campuses. His research has been published in leading academic journals including, Journal of the American Medical Association and New England Journal of Medicine.

Presentation(s):